Trial management service available for free amid COVID-19 pandemic

By Vassia Barba contact

- Last updated on GMT

(Image: Getty/farosofa)
(Image: Getty/farosofa)

Related tags: Coronavirus, COVID-19, Clinical trial management, Clinical data, Data management

Nubilaria joins a wave of providers that is offering their services for free to researchers working on potential treatments for COVID-19, with its ACTide EDC web platform.

ACTide is an online service developed by the Italian software developer, Nubilaria, that aims to facilitate collection and management of clinical data, in order to support acceleration of drug development projects.

Among its features, the platform allows for remote monitoring of patients, and can be applied on intervention and real-world trials as well as epidemiological surveys.

Nubilaria announced that access to the platform will be allowed free-of-charge for non-profit European healthcare and research organizations in order to assist developers in their fight against the pandemic.

Franco Schiannini from Nubilaria told us that the company made this decision, seeing researchers faceing significantly pressuring timeframes, to develop a safe and effective treatment for COVID-19.

“We pledge to support as many projects as it's plausibly possible for us to support with professionality and with all due attention,” ​said Schiannini, adding that since the announcement, the company has already received interest from developers looking to benefit from the offer.

Schiannini said that more service providers should follow this example, suggesting that this is already being witnessed within the industry.

Last week, ClinOne, the developer of a software platform aiming to facilitate patient recruitment, also announced that it will be offering its service complimentary​ to developers of COVID-19 vaccines.

Related news

Related products

show more

GLP Tissue Cross Reactivity Testing

GLP Tissue Cross Reactivity Testing

Precision for Medicine | 11-Oct-2021 | Product Brochure

Precision for Medicine's unique combination of research services and tissue procurement capabilities form the pillars of our GLP Tissue Cross Reactivity...

Automating clinical trials for success

Automating clinical trials for success

Formedix | 06-Oct-2021 | Technical / White Paper

This article gives gives a brief overview of why automation is absolutely essential for clinical trial success.

Related suppliers

Follow us

Products

View more

Webinars